Altogether these findings suggest that the epigenetic regulation of Notch1 signaling through the modulation of either miRNA or posttranslational histone modification could be a novel strategy for preventing the reactivation of this developmental pathway in podocytes during glomerular disease and a potential therapeutic intervention that confers protection against DN. The gene discussed is NOTCH1; the disease is glomerular disorder.